Voyager Therapeutics grants 50,000 RSUs to SVP
Shiferman Gregory L. reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Shiferman Gregory L. reported acquisition or exercise transactions in this Form 4 filing.
Voyager Therapeutics, Inc. granted 50,000 restricted stock units (RSUs) to SVP and General Counsel Gregory L. Shiferman as equity compensation. Each RSU represents one share of common stock upon vesting.
The award was granted on April 1, 2026 under the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan. The RSUs vest over three years: one-third on the first anniversary of the grant date and one-third on each of the next two anniversaries, contingent on his continued service. After this grant, he holds 50,000 shares/RSUs directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 50,000 shares
Grant/Award
1 txn
Insider
Shiferman Gregory L.
Role
SVP and General Counsel
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 50,000 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 50,000 shares (Direct)
Footnotes (1)
- F1. Consists of shares of common stock issuable under an aggregate of 50,000 restricted stock units ("RSUs") awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan (the "Plan"). Each RSU represents the right to receive one share of common stock upon vesting. The vesting commencement date of the RSU award is the grant date, April 1, 2026. The RSU award vests over three years, with 1/3rd of the shares of common stock underlying the RSU award vesting on the one-year anniversary of such vesting commencement date and an additional 1/3rd of the shares of common stock underlying the RSU award vesting at the end of each successive one-year period thereafter, subject to the Reporting Person's continued service.
Key Figures
RSU grant size: 50,000 RSUs
Grant price per share: $0.0000 per share
Post-grant holdings: 50,000 shares/RSUs
+1 more
4 metrics
RSU grant size
50,000 RSUs
Equity award to SVP and General Counsel on April 1, 2026
Grant price per share
$0.0000 per share
Compensation grant, not an open-market purchase
Post-grant holdings
50,000 shares/RSUs
Total direct holdings following the reported transaction
Vesting period
3 years
RSUs vest in three equal annual installments from April 1, 2026
Key Terms
restricted stock units, vesting commencement date, 2025 Stock Incentive Plan, continued service
4 terms
restricted stock units financial
"Consists of shares of common stock issuable under an aggregate of 50,000 restricted stock units ("RSUs")"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
vesting commencement date financial
"The vesting commencement date of the RSU award is the grant date, April 1, 2026."
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
2025 Stock Incentive Plan financial
"awarded to the Reporting Person pursuant to the Voyager Therapeutics, Inc. 2025 Stock Incentive Plan (the "Plan")."
continued service financial
"thereafter, subject to the Reporting Person's continued service."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Voyager Therapeutics (VYGR) report for Gregory L. Shiferman?
Gregory L. Shiferman received 50,000 restricted stock units from Voyager Therapeutics as an equity grant. These RSUs were awarded under the 2025 Stock Incentive Plan and represent potential future shares of common stock, subject to a multi-year vesting schedule tied to continued service.
What is the vesting schedule for Gregory L. Shiferman’s 50,000 Voyager (VYGR) RSUs?
The 50,000 RSUs vest over three years starting April 1, 2026. One-third vests on the first anniversary of that date, and the remaining two-thirds vest in equal one-third installments at the end of each successive one-year period, subject to continued service.
Did Gregory L. Shiferman pay anything for his Voyager Therapeutics (VYGR) RSU award?
The RSU award was reported at a price of $0.0000 per share, indicating it was a compensation grant rather than a purchase. He did not buy these shares on the open market; they are equity incentives under the company’s 2025 Stock Incentive Plan.
What is Gregory L. Shiferman’s position at Voyager Therapeutics (VYGR)?
Gregory L. Shiferman serves as Senior Vice President and General Counsel at Voyager Therapeutics. The reported RSU grant aligns his compensation partly with the company’s stock, linking his long-term incentives to Voyager’s share performance and his continued service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
